Interleukin-5 production inhibitor

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 17/08 (2006.01) A61K 31/70 (2006.01)

Patent

CA 2196878

Object: to provide an erythromycin derivative having a potent interleukin-5 production inhibitory effect. Constitution: an interleukin-5 production inhibitor containing as the active ingredient an erythromycin derivative, such as 6-O-methylerythromycin A 9-[O-(2-chlorophenylmethyl)oxime], 6-O- methylerythromycin A 9-[O-(3-methoxy-4-t-butylbenzyl)oxime] 11,12-cyclic carbonate or 11-amino-9-N, 11-N-cyclic ethylene-9-deoxo-11-deoxy-6-O- methylerythromycin A 9-benzylamine 11-N, 12-O-cyclic carbamate, or a medicinally acceptable acid-addition salt thereof.

Un dérivé de l'érythromycine présente un puissant effet inhibiteur de la production d'interleukine-5. Ce dérivé d'érythromycine, ingrédient actif de l'inhibiteur de production d'interleukine-5, peut être 6-O-méthylérythromycine A 9-[O-(2-chlorophénylméthyl)oxyme], carbonate de 6-O-méthylérythromycine A 9-[O-(3-méthoxy-4-t-butylbenzyl)oxyme] 11,12-cyclique ou 11-amino-9-N, 11-N-cyclique éthylène-9-déoxo-11-déoxy-6-O-méthylérythromycine A 9-benzylamine 11-N, carbamate 12-O-cyclique, ou l'un de leurs sels d'addition d'acide médicalement acceptable.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Interleukin-5 production inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Interleukin-5 production inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin-5 production inhibitor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1837666

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.